-
healthcare411.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/hospital/qitoolkit/combined/c1_combo_prioritizationworksheet.xlsx
July 01, 2016 - Trauma-Vaginal Delivery With Instrument
PSI 19 Obstetric Trauma-Vaginal Delivery Without Instrument
Death … PSI 02 Death in Low-Mortality DRGs
PSI 04 Death Among Surgical Inpatients
Sentinel Events (Adults
-
talkingquality.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/hospital/qitoolkit/combined/c1_combo_prioritizationworksheet.xlsx
July 01, 2016 - Trauma-Vaginal Delivery With Instrument
PSI 19 Obstetric Trauma-Vaginal Delivery Without Instrument
Death … PSI 02 Death in Low-Mortality DRGs
PSI 04 Death Among Surgical Inpatients
Sentinel Events (Adults
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/hospital/qitoolkit/combined/c1_combo_prioritizationworksheet.xlsx
July 01, 2016 - Trauma-Vaginal Delivery With Instrument
PSI 19 Obstetric Trauma-Vaginal Delivery Without Instrument
Death … PSI 02 Death in Low-Mortality DRGs
PSI 04 Death Among Surgical Inpatients
Sentinel Events (Adults
-
www.cahps.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-88-references.pdf
August 12, 2012 - Review of AERS Data from Marketed Safety Experience During Stimulant Therapy:
Death, Sudden Death, Cardiovascular … Review of AERS Data from Marketed Safety Experience During Stimulant Therapy:
Death, Sudden Death, Cardiovascular … Sudden death and use of stimulant medications in
youths. Am J Psychiatry. 2009;166(9):992-1001.
-
www.cahps.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-references.pdf
August 12, 2012 - Review of AERS Data from Marketed Safety Experience During Stimulant Therapy:
Death, Sudden Death, Cardiovascular … Review of AERS Data from Marketed Safety Experience During Stimulant Therapy:
Death, Sudden Death, Cardiovascular … Sudden death and use of stimulant medications in
youths. Am J Psychiatry. 2009;166(9):992-1001.
-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-references.pdf
August 12, 2012 - Review of AERS Data from Marketed Safety Experience During Stimulant Therapy:
Death, Sudden Death, Cardiovascular … Review of AERS Data from Marketed Safety Experience During Stimulant Therapy:
Death, Sudden Death, Cardiovascular … Sudden death and use of stimulant medications in
youths. Am J Psychiatry. 2009;166(9):992-1001.
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-88-references.pdf
August 12, 2012 - Review of AERS Data from Marketed Safety Experience During Stimulant Therapy:
Death, Sudden Death, Cardiovascular … Review of AERS Data from Marketed Safety Experience During Stimulant Therapy:
Death, Sudden Death, Cardiovascular … Sudden death and use of stimulant medications in
youths. Am J Psychiatry. 2009;166(9):992-1001.
-
www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-references.pdf
August 12, 2012 - Review of AERS Data from Marketed Safety Experience During Stimulant Therapy:
Death, Sudden Death, Cardiovascular … Review of AERS Data from Marketed Safety Experience During Stimulant Therapy:
Death, Sudden Death, Cardiovascular … Sudden death and use of stimulant medications in
youths. Am J Psychiatry. 2009;166(9):992-1001.
-
www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-88-references.pdf
August 12, 2012 - Review of AERS Data from Marketed Safety Experience During Stimulant Therapy:
Death, Sudden Death, Cardiovascular … Review of AERS Data from Marketed Safety Experience During Stimulant Therapy:
Death, Sudden Death, Cardiovascular … Sudden death and use of stimulant medications in
youths. Am J Psychiatry. 2009;166(9):992-1001.
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-references.pdf
August 12, 2012 - Review of AERS Data from Marketed Safety Experience During Stimulant Therapy:
Death, Sudden Death, Cardiovascular … Review of AERS Data from Marketed Safety Experience During Stimulant Therapy:
Death, Sudden Death, Cardiovascular … Sudden death and use of stimulant medications in
youths. Am J Psychiatry. 2009;166(9):992-1001.
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-references.pdf
August 12, 2012 - Review of AERS Data from Marketed Safety Experience During Stimulant Therapy:
Death, Sudden Death, Cardiovascular … Review of AERS Data from Marketed Safety Experience During Stimulant Therapy:
Death, Sudden Death, Cardiovascular … Sudden death and use of stimulant medications in
youths. Am J Psychiatry. 2009;166(9):992-1001.
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-88-references.pdf
August 12, 2012 - Review of AERS Data from Marketed Safety Experience During Stimulant Therapy:
Death, Sudden Death, Cardiovascular … Review of AERS Data from Marketed Safety Experience During Stimulant Therapy:
Death, Sudden Death, Cardiovascular … Sudden death and use of stimulant medications in
youths. Am J Psychiatry. 2009;166(9):992-1001.
-
www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-references.pdf
August 12, 2012 - Review of AERS Data from Marketed Safety Experience During Stimulant Therapy:
Death, Sudden Death, Cardiovascular … Review of AERS Data from Marketed Safety Experience During Stimulant Therapy:
Death, Sudden Death, Cardiovascular … Sudden death and use of stimulant medications in
youths. Am J Psychiatry. 2009;166(9):992-1001.
-
www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-88-references.pdf
August 12, 2012 - Review of AERS Data from Marketed Safety Experience During Stimulant Therapy:
Death, Sudden Death, Cardiovascular … Review of AERS Data from Marketed Safety Experience During Stimulant Therapy:
Death, Sudden Death, Cardiovascular … Sudden death and use of stimulant medications in
youths. Am J Psychiatry. 2009;166(9):992-1001.
-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-88-references.pdf
August 12, 2012 - Review of AERS Data from Marketed Safety Experience During Stimulant Therapy:
Death, Sudden Death, Cardiovascular … Review of AERS Data from Marketed Safety Experience During Stimulant Therapy:
Death, Sudden Death, Cardiovascular … Sudden death and use of stimulant medications in
youths. Am J Psychiatry. 2009;166(9):992-1001.
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-88-references.pdf
August 12, 2012 - Review of AERS Data from Marketed Safety Experience During Stimulant Therapy:
Death, Sudden Death, Cardiovascular … Review of AERS Data from Marketed Safety Experience During Stimulant Therapy:
Death, Sudden Death, Cardiovascular … Sudden death and use of stimulant medications in
youths. Am J Psychiatry. 2009;166(9):992-1001.
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-references.pdf
August 12, 2012 - Review of AERS Data from Marketed Safety Experience During Stimulant Therapy:
Death, Sudden Death, Cardiovascular … Review of AERS Data from Marketed Safety Experience During Stimulant Therapy:
Death, Sudden Death, Cardiovascular … Sudden death and use of stimulant medications in
youths. Am J Psychiatry. 2009;166(9):992-1001.
-
nhqrnet.ahrq.gov/inhqrdr/National/trend/table/Diseases_and_Conditions/Cardiovascular_Disease
Home
National View
Diseases & Conditions
Cardiovascular Disease
Trend Summary
Trend Data
Back to National Cardiovascular Disease Trend Bar Graphs
National Cardiovascular Disease Quality Measures Trend Over Time
Trending information is available for NHQDR quality measures with at least four years o…
-
effectivehealthcare.ahrq.gov/decision-aids/lung-cancer-screening/static/lung-cancer-screening-clin-summary.pdf
March 01, 2016 - The median age at death was
72 years, and the number of deaths was 47
per 100,000 people.
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/lung-cancer-screening-clin-summary.pdf
March 01, 2016 - The median age at death was
72 years, and the number of deaths was 47
per 100,000 people.